Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 841 AL 855

The other side of the histamine H3 receptor

Ellenbroek BA, Ghiabi B.

Trends Neurosci. 2014 Apr;37(4):191-9. doi: 10.1016/j.tins.2014.02.007. Epub 2014 Mar 11.

Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: post-hoc analyses from the ADAGIO trial

Jankovic J, Berkovich E, Eyal E, Tolosa E.

Parkinsonism Relat Disord. 2014 Jun;20(6):640-3. doi: 10.1016/j.parkreldis.2014.02.024. Epub 2014 Mar 5.

The emerging role of nutrition in Parkinson's disease

Seidl SE, Santiago JA, Bilyk H, Potashkin JA.

Front Aging Neurosci. 2014 Mar 7;6:36. doi: 10.3389/fnagi.2014.00036. eCollection 2014.

Therapeutic application of intrabodies against age-related neurodegenerative disorders

Cardinale A, Merlo D, Giunchedi P, Biocca S.

Curr Pharm Des. 2014;20(38):6028-36. doi: 10.2174/1381612820666140314121444.

A rare manifestation of atrial fibrillation in the presence of Wolff-Parkinson-White syndrome: tachycardia-induced cardiomyopathy

Değirmencioğu A, Karakuş G, Baysal E, Zencirci E, Çakmak N.

Turk Kardiyol Dern Ars. 2014 Mar;42(2):178-81. doi: 10.5543/tkda.2014.69812.

A randomized study of rotigotine dose response on 'off' time in advanced Parkinson's disease

Nicholas AP, Borgohain R, Chaná P, Surmann E, Thompson EL, Bauer L, Whitesides J, Elmer LW; SP921 Study Investigators.

J Parkinsons Dis. 2014;4(3):361-73. doi: 10.3233/JPD-130320.

Dicarbonyl proteome and genome damage in metabolic and vascular disease

Rabbani N, Thornalley PJ.

Biochem Soc Trans. 2014 Apr;42(2):425-32. doi: 10.1042/BST20140018.

Insulin, incretins and other growth factors as potential novel treatments for Alzheimer's and Parkinson's diseases

Hölscher C.

Biochem Soc Trans. 2014 Apr;42(2):593-9. doi: 10.1042/BST20140016.

Glutamatergic pathways as a target for the treatment of dyskinesias in Parkinson's disease

Cenci MA.

Biochem Soc Trans. 2014 Apr;42(2):600-4. doi: 10.1042/BST20140006.

Regulation of mitochondrial dynamics and cell fate

Dhingra R, Kirshenbaum LA.

Circ J. 2014;78(4):803-10. doi: 10.1253/circj.cj-14-0240. Epub 2014 Mar 20.

Safinamide for the treatment of Parkinson's disease

Dézsi L, Vécsei L.

Expert Opin Investig Drugs. 2014 May;23(5):729-42. doi: 10.1517/13543784.2014.897694. Epub 2014 Mar 21.

Investigation of morphometric variability of subthalamic nucleus, red nucleus, and substantia nigra in advanced Parkinson's disease patients using automatic segmentation and PCA-based analysis

Xiao Y, Jannin P, D'Albis T, Guizard N, Haegelen C, Lalys F, Vérin M, Collins DL.

Hum Brain Mapp. 2014 Sep;35(9):4330-44. doi: 10.1002/hbm.22478. Epub 2014 Feb 19.

Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders

Maffioletti E, Tardito D, Gennarelli M, Bocchio-Chiavetto L.

Front Cell Neurosci. 2014 Mar 11;8:75. doi: 10.3389/fncel.2014.00075. eCollection 2014.

[Clinical studies with levodopa/carbidopa intestinal gel]

Klivényi P, Vécsei L.

Ideggyogy Sz. 2014 Jan 30;67(1-2):5-8.

Could a new sensory pen assist in the early diagnosis of Parkinson's?

Walker RW, Zietsma R, Gray WK.

Expert Rev Med Devices. 2014 May;11(3):243-5. doi: 10.1586/17434440.2014.900437. Epub 2014 Mar 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias